Pyrrolopyridinylpyrimidin-2-ylamine derivatives

Compounds of the formula I

• in which
• R1 denotes H or A,
• R2 denotes A, Hal, CN, (CH2)nCONH(CH2)pAr, —C(OH)R5—Ar, —[C(R)2]n—Ar, —[C(R5)2]n-Het, —[C(R5)2]n-cycloalkyl, —NR5A, —NR5Ar, NR5Het, —[C(R5)2]mN(R5)2, 1-hydroxycyclopentan-1-yl or 1-hydroxycyclohexan-1-yl,
• R3 denotes H, R5, —[C(R5)2]n—Ar, —[C(R5)2]n-Het, —[C(R5)2]n-cycloalkyl,
• R4 denotes H, Het-, Ar—, —R5, —OR5, —[C(R6)2]C(O)N(R6)2, CO-Het or O(CH2)pHet1,
• R5 denotes H, A or cycloalkyl,
• R6 denotes H or A′,
• A′ denotes unbranched or branched alkyl having 1-10 C atoms, in which 1-7 H atoms may be replaced by F,
• cycloalkyl denotes cyclic alkyl having 3-7 C atoms, which may additionally be substituted by alkyl having 1-6 C atoms,
• A denotes unbranched or branched alkyl having 1-10 C atoms, in which one or two CH and/or CH2 groups may be replaced by N, O, S atoms and/or by —CH═CH— groups and/or in addition 1-7 H atoms may be replaced by F,
• X denotes NH, O, S or SO2,
• Ar denotes phenyl which is unsubstituted or mono-, di- or trisubstituted by Hal, A, OR5, N(R5)2, NO2, CN, COOR5, CON(R5)2, NR5COA, NR5SO2A, COR5, SO2N(R)2 and/or S(O)pA,
• Het denotes a mono- or bicyclic saturated, unsaturated or aromatic heterocycle having 1 to 4 N, and/or O and/or S atoms which is unsubstituted or mono- or disubstituted by Hal, A, OR5, (CH2)pN(R5)2, NO2, CN, (CH2)pCOOR5, (CH2)pCON(R5)2, NR5COA, (CH2)pHet1, (CH2)pCOHet1, NR5SO2A, COR5, SO2NR5 and/or S(O)pA,
• Het1 denotes a saturated heterocycle having 1 to 4 N, O, and or S atoms which is unsubstituted or mono- or disubstituted by A, S(O)pA and/or COA,
• Hal denotes F, Cl, Br or I,
• m denotes 1, 2, 3 or 4,
• n denotes 0, 1, 2, 3 or 4,
• p denotes 0, 1 or 2,
• and pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.